AYTUNasdaq United States
Market cap
$25.330 M
$2.36 +1.29%
Close of 7 Aug 2026
Revenue
$66.4M
#2655 by revenue
Earnings
-$13.6M
Loss-making
Shares outstanding
10,733,208
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Aytu Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.